Search research articles
Contact Us
Filters
Showing results (131-140 of 684) with videos related to
Page
of 69
Sort By:
Toxicon : Official Journal of the International Society on Toxinology
|
December 24, 2008
Treatment of focal dystonias with botulinum neurotoxin
Mark Hallett, Reiner Benecke, Andrew Blitzer, et al.
Cardiovascular Research
|
November 23, 2007
An alternative view of apoptosis in heart development and disease
Daniel Sanchis, Marta Llovera, Manel Ballester, et al.
Postgraduate Medicine
|
June 4, 2021
On demand therapy for Parkinson's disease patients: Opportunities and choices
Robert A Hauser, Peter A LeWitt, Cynthia L Comella
Cancer
|
January 3, 2001
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group
A Daponte, P A Ascierto, A Gravina, et al.
British Journal of Cancer
|
October 19, 2006
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study
G Frasci, G D'Aiuto, P Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group
P Comella, R Casaretti, F De Vita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer
G Frasci, P Comella, M Rinaldo, et al.
Oncology
|
March 13, 2001
Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group
P Comella, M Biglietto, R Casaretti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 1996
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies
P Comella, G Palmieri, V Lorusso, et al.
Digestive Surgery
|
August 31, 2001
Neuromuscular and vascular hamartoma of the small intestine
F Scintu, M Giordano, R Mascia, et al.
Page
of 69
Search research articles
Search
Showing results (131-140 of 684) with videos related to
Sort By:
Page
of 69
Toxicon : Official Journal of the International Society on Toxinology
|
December 24, 2008
Treatment of focal dystonias with botulinum neurotoxin
Mark Hallett, Reiner Benecke, Andrew Blitzer, et al.
Cardiovascular Research
|
November 23, 2007
An alternative view of apoptosis in heart development and disease
Daniel Sanchis, Marta Llovera, Manel Ballester, et al.
Postgraduate Medicine
|
June 4, 2021
On demand therapy for Parkinson's disease patients: Opportunities and choices
Robert A Hauser, Peter A LeWitt, Cynthia L Comella
Cancer
|
January 3, 2001
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group
A Daponte, P A Ascierto, A Gravina, et al.
British Journal of Cancer
|
October 19, 2006
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study
G Frasci, G D'Aiuto, P Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group
P Comella, R Casaretti, F De Vita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer
G Frasci, P Comella, M Rinaldo, et al.
Oncology
|
March 13, 2001
Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group
P Comella, M Biglietto, R Casaretti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 1996
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies
P Comella, G Palmieri, V Lorusso, et al.
Digestive Surgery
|
August 31, 2001
Neuromuscular and vascular hamartoma of the small intestine
F Scintu, M Giordano, R Mascia, et al.
Page
of 69